Acushnet Looks 7% Undervalued After a Big Earnings Beat and Fresh Buybacks

The second-quarter beat shifted the debate

Acushnet still looks about 7% undervalued after its latest report, and the market may be underpricing a second reset: not just a better quarter, but a more credible move onto a higher earnings path. The results were broad-based rather than cosmetic. Acushnet delivered EPS of $2.08, beating consensus by $0.45 on Q2 revenue of $820.0 million, up 13.8%. Net income rose 65.1%, and adjusted EBITDA margin expanded to 25.4%. Even at a 33.19 P/E Ratio, the stock can still look too low if this quarter marks the point where earnings begin compounding faster than investors expect.

Why investors are reading the quarter differently

Bulls can fairly argue that this is what re-acceleration looks like: fast top-line growth, stronger margins, and profits improving faster than sales. Bears have a simpler counter: one strong quarter does not erase last year's pressure, especially after full-year 2025 net sales up 4.1%. That is the real split in the market. The burden of proof has shifted from showing Acushnet was weak to showing this quarter was a spike rather than the start of a better trend.

Why waiting could prove costly

This report raised the bar for the rest of 2026. Management is still targeting full-year 2026 net sales expected between $2,650 million and $2,675 million after a quarter this strong. If the next few quarters preserve even part of this quality, delayed re-rating could leave money on the table.

Why the market is still hesitant

That hesitation is understandable because Acushnet's recent low point was hard to ignore. The company ended 2025 with a Q4 net loss of $34.9 million and only $9.8 million of Q4 adjusted EBITDA. Even the broader 2025 backdrop was only modestly positive, with full-year sales up 4.1%. In practice, that means investors are still anchored to the weak finish and want firmer proof before fully crediting a turn.

The bull case and the bear case

The bear case is not baseless. One strong quarter does not erase a difficult year-end, and 2025 sales growth still looks more like stabilization than a clean breakout.

The bull case, though, rests on a cleaner sequence. The first half of this year saw first-half net sales up 10.5% after that weak fourth quarter. Just as important, the channel looked healthier: Inventory decreased to $532 million as of June 30, 2026, from $609 million at year-end 2025. Recoveries often show up in demand and working capital before the income statement looks perfectly smooth.

Guidance is the clearest sign of change

The most important clue is the shift in earnings expectations. In February, Acushnet introduced 2026 guidance for $2.625 billion to $2.675 billion in net sales and $415 million to $435 million in adjusted EBITDA. By the second-quarter update, sales guidance remained near the top end, while adjusted EBITDA guidance moved to $450 million to $470 million. That is the key repricing lever: if sales are holding steady while earnings guidance rises, the old anchor may no longer match the operating trend.

What would weaken the catch-up thesis

This is still a debate, not a certainty. The catch-up case weakens if the next reports show:

• sales momentum fades back toward the prior year's pace;
• margins contract rather than hold or improve;
• channel conditions stop improving, including inventory behavior.

If those signals hold, hesitation could become opportunity. If they break, skepticism was probably justified.

Buybacks make the per-share upside more concrete

That operating improvement matters even more because Acushnet is reducing the share count at the same time.

The per-share math is improving faster than the headline math

In Q2, Acushnet bought back 182,231 shares for US$16 million, representing 0.31% of its shares. That is not a token gesture. It means a rising profit pool is being spread over fewer shares, which can lift earnings per share faster than the income statement alone would imply. This also was not a one-quarter event. The company said the repurchase program has now retired 19,458,060 shares in total, or 29.33% of the company since 2018.

Why the multiple can be misleading on its own

The market can focus on a roughly 33.19 P/E Ratio and conclude the stock already prices in too much. But that view can understate the compounding effect of capital returns. With trailing EPS of $2.84 and expected EPS growth of 9.87% next year, Acushnet is not just growing earnings; it is concentrating them. For investors focused on per-share wealth, that can matter as much as the headline multiple.

What to watch next

The next quarter should clarify whether this capital-allocation edge is still adding fuel:

• whether repurchases continue at a meaningful pace;
• whether earnings growth keeps tracking or exceeds sales growth;
• whether management's 2026 earnings outlook remains firm.

If those signals hold, buybacks stop being a helpful backdrop and become part of the near-term upside engine.